Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization

Translation of cell therapies into clinical practice requires the adoption of robust production protocols in order to optimize and standardize the manufacture and cryopreservation of cells, in compliance with good manufacturing practice regulations. Between 2012 and 2020, we conducted two phase I cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Profico, Daniela Celeste, Gelati, Maurizio, Ferrari, Daniela, Sgaravizzi, Giada, Ricciolini, Claudia, Projetti Pensi, Massimo, Muzi, Gianmarco, Cajola, Laura, Copetti, Massimiliano, Ciusani, Emilio, Pugliese, Raffaele, Gelain, Fabrizio, Vescovi, Angelo Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653902/
https://www.ncbi.nlm.nih.gov/pubmed/36362211
http://dx.doi.org/10.3390/ijms232113425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653902/
https://www.ncbi.nlm.nih.gov/pubmed/36362211
http://dx.doi.org/10.3390/ijms232113425

Ejemplares similares